Comparative analysis of IL6 and IL6 receptor gene polymorphisms in mastocytosis

British Journal of Haematology

Volumn 160, Issue 2, 2013, Pages 216-219

  Rausz, Eszter ^a   Szilágyi, Agnes ^a,c   Nedoszytko, Boguslaw ^b   Lange, Magdalena ^b   Niedoszytko, Marek ^b   Lautner Csorba, Orsolya ^c   Falus, András ^c   Aladzsity, István ^a   Kokai, Márta ^a   Valent, Peter ^d   Marschalko, Márta ^c   Hidvégi, Bernadett ^c   Szakonyi, József ^c   Csomor, Judit ^c   Várkonyi, Judit ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Genetic polymorphism; IL6; IL6R; Mastocytosis

Indexed keywords

ALANINE; ASPARTIC ACID; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; IL6 GENE; IL6R GENE; MAJOR CLINICAL STUDY; MALE; MASTOCYTOSIS; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; AUSTRIA; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HUNGARY; INTERLEUKIN-6; LEUKEMIA, MAST-CELL; MALE; MASTOCYTOSIS; MIDDLE AGED; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-6; YOUNG ADULT;

EID: 84872265226     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12086     Document Type: Article

References (15)

1. Aladzsity, I., Kovacs, M., Semsei, A., Falus, A., Szilagyi, A., Karadi, I., Varga, G., Fust, G. & Varkonyi, J. (2009) Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma. Leukemia Research, 33, 1570-1573.
2. Brockow, K., Akin, C., Huber, M. & Metcalfe, D.D. (2005) IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis. Clinical Immunology, 115, 216-223.
3. Cardama, A.Q., Vaddi, K., Liu, P., Manshouri, T., Li, J., Scherle, P.A., Caulder, E., Wen, X., Li, Y., Waeltz, P., Rupar, M., Burn, T., Lo, Y., Kelley, J., Covington, M., Shepard, S., Rodgers, J.D., Haley, P., Kantarjian, H., Fridman, J.S. & Verstovsek, S. (2010) Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood, 115, 3109-3117.
4. Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S. & Woo, P. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation, 102, 1369-1376.
5. Galicia, J.C., Tai, H., Komatsu, Y., Shimada, Y., Akazawa, K. & Yoshie, H. (2004) Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced. Genes and Immunity, 5, 513-516.
6. Horny, H., Metcalfe, D., Bennett, J., Bain, B., Akin, C., Escribano, L. & Valent, P. (2008) Mastocytosis. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn (ed. by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman ), pp. 54-63. IARC Press, Lyon, France.
7. Orfao, A., Garcia-Montero, A.C., Sanchez, L. & Escribano, L. (2007) Recent advances in the understanding of mastocytosis: the role of KIT mutations. British Journal of Haematology, 138, 12-30.
8. Panteli, K.E., Hatzimichael, E.C., Bouranta, P.K., Katsaraki, A., Seferiadis, K., Stebbing, J. & Bourantas, K.L. (2005) Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases. British Journal of Haematology, 130, 709-715.
9. Qi, L., van Dam, R.M., Meigs, J.B., Manson, J.E., Hunter, D. & Hu, F.B. (2006) Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Human Molecular Genetics, 15, 1914-1920.
10. Reich, D., Patterson, N., Ramesh, V., De Jager, P.L., McDonald, G.J., Tandon, A., Choy, E., Hu, D., Tamraz, B., Pawlikowska, L., Wassel-Fyr, C., Huntsman, S., Waliszewska, A., Rossin, E., Li, R., Garcia, M., Reiner, A., Ferrell, R., Cummings, S., Kwok, P.Y., Harris, T., Zmuda, J.M. & Ziv, E. (2007) Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. American Journal of Human Genetics, 80, 716-726.
11. Rivera-Chavez, F.A., Peters-Hybki, D.L., Barber, R.C. & O'Keefe, G.E. (2003) Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock, 20, 218-223.
12. Rose-John, S., Scheller, J., Elson, G. & Jones, S.A. (2006) Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. Journal of Leukocyte Biology, 80, 227-236.
13. Tefferi, A. (2000) Myelofibrosis with myeloid metaplasia. New England Journal of Medicine, 342, 1255-1265.
14. Valent, P., Akin, C., Escribano, L., Fodinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W.R., Kluin-Nelemans, H.C., Hamdy, N.A., Lortholary, O., Robyn, J., van Doormaal, J., Sotlar, K., Hauswirth, A.W., Arock, M., Hermine, O., Hellmann, A., Triggiani, M., Niedoszytko, M., Schwartz, L.B., Orfao, A., Horny, H.P. & Metcalfe, D.D. (2007) Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. European Journal of Clinical Investigation, 37, 435-453.
15. Wickenhauser, C., Thiele, J., Lorenzen, J., Schmitz, B., Frimpong, S., Schramm, K., Neumann, I., Zankovich, R. & Fischer, R. (1999) Polycythemia vera megakaryocytes but not megakaryocytes from normal controls and patients with smokers polyglobuly spontaneously express IL-6 and IL-6R and secrete IL-6. Leukemia, 13, 327-334.